First quarter revenue of $1.26 billion First quarter GAAP EPS from continuing operations of $1.40; Adjusted EPS of $2.41 Initiates Second Quarter and Raises Full Year Guidance WALTHAM, Mass.–(BUSINESS WIRE)–May 3, 2022– PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today reported financial results for the first quarter ended... Read more
Innovations and expertise centered on accelerating therapeutic and personalized medicine R&D WHAT: PerkinElmer, Inc., a global leader committed to innovating for a healthier world, is participating at the Bio-IT World Conference and Expo, May 3-5, in Boston, MA (booths #908, #912), with a focus on helping labs make well-informed and timely data-driven decisions on therapeutic... Read more
WALTHAM, Mass.–(BUSINESS WIRE)– Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the first quarter ended April 2, 2022. First Quarter 2022 Highlights First quarter revenue was $11.82 billion. First quarter GAAP diluted earnings per share (EPS) was $5.61. First quarter adjusted EPS was $7.25. Delivered... Read more
New FluoroType® Mycobacteria PCR assay detects the mycobacteria complex and differentiates 32 clinically relevant mycobacteria species from culture, using LiquidArray® multiplex PCR technology* New FluoroType® STI PCR assay detects seven major pathogens causing Sexually Transmitted Infections (STIs), using LiquidArray® multiplex PCR technology* New MBT Compass HT IVD software provides significantly increased speed for microbial identification... Read more
WASHINGTON, April 21, 2022 /PRNewswire/ — Danaher Corporation (NYSE: DHR) (the “Company”) today announced results for the first quarter 2022. For the quarter ended April 1, 2022, net earnings were $1.7 billion, or $2.31 per diluted common share which represents a 1.0% increase over the comparable 2021 period. Non-GAAP adjusted diluted net earnings per common... Read more
Part of Ongoing Commitment to Build a More Sustainable and Equitable Future RYE BROOK, N.Y.–(BUSINESS WIRE)–Apr. 19, 2022– Xylem Inc. (NYSE: XYL), a leading global water technology company dedicated to solving the world’s most challenging water issues, announced today an initial commitment to invest $5 million of its on-hand capital in mission-driven financial institutions that... Read more
Leading developer of assays for T cell measurement introduces Certimmune global immunology services to support vaccine manufacturers in their phased clinical trials WHAT: Oxford Immunotec, a PerkinElmer company, will exhibit at the World Vaccine Congress in Washington D.C. from April 18-21. This live, in-person event is the largest, most established meeting covering the entire vaccine... Read more
Danaher Announces Conversion Date For Series A Mandatory Convertible Preferred Stock WASHINGTON, April 12, 2022 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced today that its 4.75% Series A Mandatory Convertible Preferred Stock (the “Preferred Stock”), will automatically convert into shares of the Company’s Common Stock on April 15, 2022 (the “Conversion Date”). The conversion rate... Read more
Innovative solutions offer researchers flexible therapeutic tools to deepen understanding of cancer’s biology to enable advances in immunotherapy, targeted treatments, and personalized medicine WHAT: PerkinElmer, Inc., a global leader committed to innovating for a healthier world, will be at The American Association for Cancer Research (AACR) Annual Meeting from April 8-13 in New Orleans (booths... Read more
Launches first-of-its-kind automated ultrasound platform to accelerate preclinical research WALTHAM, Mass.–(BUSINESS WIRE)–Apr. 7, 2022– PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced the expansion of its in vivo imaging portfolio with the launch of the Vega® imaging system, a first-of-its kind ultrasound platform that combines hands-free, automated... Read more